Literature DB >> 27926645

Association Between Sleep-Disordered Breathing and Hypertensive Disorders of Pregnancy and Gestational Diabetes Mellitus.

Francesca L Facco1, Corette B Parker, Uma M Reddy, Robert M Silver, Matthew A Koch, Judette M Louis, Robert C Basner, Judith H Chung, Chia-Ling Nhan-Chang, Grace W Pien, Susan Redline, William A Grobman, Deborah A Wing, Hyagriv N Simhan, David M Haas, Brian M Mercer, Samuel Parry, Daniel Mobley, Shannon Hunter, George R Saade, Frank P Schubert, Phyllis C Zee.   

Abstract

OBJECTIVE: To estimate whether sleep-disordered breathing during pregnancy is a risk factor for the development of hypertensive disorders of pregnancy and gestational diabetes mellitus (GDM).
METHODS: In this prospective cohort study, nulliparous women underwent in-home sleep-disordered breathing assessments in early (6-15 weeks of gestation) and midpregnancy (22-31 weeks of gestation). Participants and health care providers were blinded to the sleep test results. An apnea-hypopnea index of 5 or greater was used to define sleep-disordered breathing. Exposure-response relationships were examined, grouping participants into four apnea-hypopnea index groups: 0, greater than 0 to less than 5, 5 to less than 15, and 15 or greater. The study was powered to test the primary hypothesis that sleep-disordered breathing occurring in pregnancy is associated with an increased incidence of preeclampsia. Secondary outcomes were rates of hypertensive disorders of pregnancy, defined as preeclampsia and antepartum gestational hypertension, and GDM. Crude and adjusted odds ratios and 95% confidence intervals (CIs) were calculated from univariate and multivariate logistic regression models.
RESULTS: Three thousand seven hundred five women were enrolled. Apnea-hypopnea index data were available for 3,132 (84.5%) and 2,474 (66.8%) women in early and midpregnancy, respectively. The corresponding prevalence of sleep-disordered breathing was 3.6% and 8.3%. The prevalence of preeclampsia was 6.0%, hypertensive disorders of pregnancy 13.1%, and GDM 4.1%. In early and midpregnancy the adjusted odds ratios for preeclampsia when sleep-disordered breathing was present were 1.94 (95% CI 1.07-3.51) and 1.95 (95% CI 1.18-3.23), respectively; hypertensive disorders of pregnancy 1.46 (95% CI 0.91-2.32) and 1.73 (95% CI 1.19-2.52); and GDM 3.47 (95% CI 1.95-6.19) and 2.79 (95% CI 1.63-4.77). Increasing exposure-response relationships were observed between apnea-hypopnea index and both hypertensive disorders and GDM.
CONCLUSION: There is an independent association between sleep-disordered breathing and preeclampsia, hypertensive disorders of pregnancy, and GDM.

Entities:  

Mesh:

Year:  2017        PMID: 27926645      PMCID: PMC5512455          DOI: 10.1097/AOG.0000000000001805

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  81 in total

1.  Association of Adverse Pregnancy Outcomes With Self-Reported Measures of Sleep Duration and Timing in Women Who Are Nulliparous.

Authors:  Francesca L Facco; Corette B Parker; Shannon Hunter; Kathryn J Reid; Phyllis C Zee; Robert M Silver; David M Haas; Judith H Chung; Grace W Pien; Chia-Ling Nhan-Chang; Hyagriv N Simhan; Samuel Parry; Ronald J Wapner; George R Saade; Brian M Mercer; Caroline Torres; Jordan Knight; Uma M Reddy; William A Grobman
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

2.  Anthropometric Measures and Prediction of Maternal Sleep-Disordered Breathing.

Authors:  Ghada Bourjeily; Alison Chambers; Myriam Salameh; Margaret H Bublitz; Amanpreet Kaur; Alexandra Coppa; Patricia Risica; Geralyn Lambert-Messerlian
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

Review 3.  Sleep Disordered Breathing, a Novel, Modifiable Risk Factor for Hypertensive Disorders of Pregnancy.

Authors:  Laura Sanapo; Margaret H Bublitz; Ghada Bourjeily
Journal:  Curr Hypertens Rep       Date:  2020-03-12       Impact factor: 5.369

4.  The National Center on Sleep Disorders Research-progress and promise.

Authors:  James P Kiley; Michael J Twery; Gary H Gibbons
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

5.  Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute.

Authors:  Christine Maric-Bilkan
Journal:  Physiol Genomics       Date:  2018-09-28       Impact factor: 3.107

6.  The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis.

Authors:  Lina Liu; Guang Su; Shuling Wang; Bingqian Zhu
Journal:  Sleep Breath       Date:  2018-09-25       Impact factor: 2.816

7.  Obstructive sleep apnea in pregnancy: performance of a rapid screening tool.

Authors:  Bilgay Izci Balserak; Bingqian Zhu; Michael A Grandner; Nicholas Jackson; Grace W Pien
Journal:  Sleep Breath       Date:  2018-09-19       Impact factor: 2.816

8.  The STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea in Pregnancy.

Authors:  Fiona Pearson; Alan M Batterham; Sean Cope
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

9.  Obstructive sleep apnea as a risk factor for preeclampsia-eclampsia.

Authors:  Nattapong Jaimchariyatam; Kunyalak Na-Rungsri; Somkanya Tungsanga; Somrat Lertmaharit; Vitool Lohsoonthorn; Surachart Totienchai
Journal:  Sleep Breath       Date:  2018-11-27       Impact factor: 2.816

10.  Cardiovascular Disease in Women Across the Lifespan: The Importance of Sleep.

Authors:  Stacie L Daugherty; Jason R Carter; Ghada Bourjeily
Journal:  J Womens Health (Larchmt)       Date:  2020-02-25       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.